MedTrace Logo

Clinical Study of the TSP Crosser System for Transseptal Access and Left Atrial Catheter Navigation

NCT02351999 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-11-15

No results posted yet for this study

Summary

The study is a prospective, multi-center, non-randomized single arm interventional investigation with the TSP Crosser Transseptal Access System, a new complete solution for transseptal puncture and left atrial access and catheter navigation, for patients with atrial fibrillation ablation referred for radiofrequency catheter ablation.

Conditions

Interventions

DEVICE

TSP Crosser Transseptal Access System

for transseptal puncture, left atrial access and catheter navigation.

Sponsors & Collaborators

  • Meditrial Europe Ltd.

    collaborator INDUSTRY

  • Transseptal Solutions Ltd.

    lead INDUSTRY

Principal Investigators

  • Monica Tocchi, MD, PhD · Meditrial Europe Ltd.

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-15
Primary Completion
2018-09-30
Completion
2019-04-30

Countries

  • France
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351999 on ClinicalTrials.gov